Aehr Test Systems financials
$100.78+2.33%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '26 Feb 27 | Q4 '25 Nov 28 | Q3 '25 Aug 29 | Q1 '25 Feb 28 | Q4 '24 Nov 29 | Q3 '24 Aug 30 | Q1 '24 Feb 29 | Q4 '23 Nov 30 | Q3 '23 Aug 31 | Q1 '23 Feb 28 | Q2 '23 Nov 30 | Q3 '22 Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3M | $9.9M | $11.0M | $18.3M | $13.5M | $13.1M | $7.6M | $21.4M | $20.6M | $17.2M | $14.8M | $10.7M |
| Gross profit | $3.4M | $2.5M | $3.7M | $7.2M | $5.4M | $7.1M | $3.2M | $11.0M | $10.0M | $8.9M | $7.9M | $4.5M |
| Gross margin | 32.7% | 25.7% | 33.9% | 39.2% | 40.1% | 54.0% | 41.7% | 51.1% | 48.4% | 51.6% | 53.4% | 42.0% |
| Operating income | -$4.2M | -$4.6M | -$4.1M | -$1.1M | -$1.5M | $159.0K | -$2.0M | $5.5M | $4.1M | $3.8M | $3.5M | $458.0K |
| Net income | -$3.2M | -$3.2M | -$2.1M | -$643.0K | -$1.0M | $660.0K | -$1.5M | $6.1M | $4.7M | $4.1M | $3.7M | $589.0K |
| Net margin | −31.1% | −32.7% | −19.0% | −3.5% | −7.6% | 5.0% | −19.4% | 28.4% | 22.7% | 24.0% | 25.1% | 5.5% |
| Diluted EPS | $-0.10 | $-0.11 | $-0.07 | $-0.02 | $-0.03 | $0.02 | $-0.05 | $0.20 | $0.16 | $0.14 | $0.13 | $0.02 |
| EBITDA | -$4.2M | -$4.9M | -$3.1M | -$1.1M | -$1.5M | $506.0K | -$2.0M | $5.5M | $4.3M | $3.8M | $3.5M | $562.0K |
| Operating cash flow | — | — | -$282.0K | — | — | $2.4M | — | -$787.0K | $3.9M | — | $3.0M | $5.5M |
| Free cash flow | — | — | -$1.7M | — | — | $2.2M | — | -$1.0M | $3.6M | — | $2.9M | $5.4M |
| Diluted shares | 30.7M | 30.2M | 29.9M | 29.7M | 29.7M | 29.6M | 28.9M | 29.8M | 29.6M | 29.4M | 29.1M | 28.8M |
Balance sheet
| Period end | May 29 | Feb 27 | Nov 28 | Aug 29 | May 30 | Feb 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $116.4M | $36.9M | $30.8M | $22.7M | $24.5M | $29.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $246.7M | $157.0M | $148.7M | $144.1M | $148.5M | $145.6M |
| Total liabilities | $27.2M | $18.3M | $18.0M | $21.7M | $25.6M | $21.4M |
| Shareholders' equity | $219.5M | $138.8M | $130.8M | $122.4M | $122.9M | $124.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology